Targeting of C-Met and AXL by Cabozantinib is a Potential Therapeutic Strategy for Patients with Head and Neck Cell Carcinoma

Anais Hagege,Esma Saada-Bouzid,Damien Ambrosetti,Olivia Rastoin,Julien Boyer,Xingkang He,Julie Rousset,Christopher Montemagno,Jerome Doyen,Florence Pedeutour,Julien Parola,Isabelle Bourget,Frederic Luciano,Alexandre Bozec,Yihai Cao,Gilles Pages,Maeva Dufies

Cell Reports Medicine（2022）

引用 18|浏览23

关键词

AXL,c-MET,head and neck squamous cell carcinoma,HNSCC,radiotherapy,cisplatin,resistance,cabozantinib,anti-angiogenic,VEGFR inhibitor,therapy repositioning

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要